Literature DB >> 20155653

[Oxidative stress in the trabecular meshwork of POAG].

U Welge-Lüssen1, K Birke.   

Abstract

Primary open angle glaucoma (POAG) is defined as an optic neuropathy which is characterised by the loss of optic nerve axons and the related retinal ganglion cells. The reason for these changes is still unknown. In the pathogenesis of POAG several factors like increased intraocular pressure and a reduction of ocular blood supply are discussed. Morphological and biochemical analyses of the trabecular meshwork (TM) of POAG patients revealed loss of cells, increased accumulation of extracellular matrix (ECM), changes in the cytoskeleton, cellular senescence and the process of subclinical inflammation. One factor becoming more likely to be involved in the pathogenesis of POAG is oxidative stress. Treatment of TM cells with oxidative stress induced POAG-typical changes like ECM accumulation, cell death, disarrangement of the cytoskeleton, advanced senescence and the release of inflammatory markers. By pretreatment with antioxidants, prostaglandin analogues, beta-blockers or local carbonic anhydrase inhibitors, these effects were markedly reduced. In conclusion, oxidative stress is able to induce characteristic glaucomatous TM changes in vitro and these oxidative stress-induced TM changes can be minimised by the use of antioxidants and IOP-lowering substances. It is tempting to speculate that prevention of oxidative stress exposure to the TM may help to reduce the progression of POAG. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155653     DOI: 10.1055/s-0029-1245171

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  13 in total

1.  [Importance of perimetric differential diagnostics in patients with primary open-angle glaucoma].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

Review 2.  [Suprachoroidal minimally invasive glaucoma surgery : Procedures and clinical outcome].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

3.  Cod liver oil: a potential protective supplement for human glaucoma.

Authors:  Wen-Bin Huang; Qian Fan; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

4.  Induction of trabecular meshwork cells from induced pluripotent stem cells.

Authors:  Qiong J Ding; Wei Zhu; Amy C Cook; Kristin R Anfinson; Budd A Tucker; Markus H Kuehn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-08       Impact factor: 4.799

Review 5.  [Structural alterations during the course of glaucoma disease].

Authors:  C Y Mardin; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

6.  Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma.

Authors:  Ugur Yilmaz Mumcu; Ibrahim Kocer; Orhan Ates; H Hakan Alp
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

7.  Adenosine A3 receptor activated in H2O2 oxidative stress of primary open-angle glaucoma.

Authors:  Ziyu Zhou; Zhaolin Gao; Weitao Yan; Yun Zhang; Jufang Huang; Kun Xiong
Journal:  Ann Transl Med       Date:  2021-04

8.  Switch to Autophagy the Key Mechanism for Trabecular Meshwork Death in Severe Glaucoma.

Authors:  Aparna Rao; Prity Sahay; Munmun Chakraborty; Birendra Kumar Prusty; Sandhya Srinivasan; Gagan Deep Jhingan; Pragyan Mishra; Rahul Modak; Mrutyunjay Suar
Journal:  Clin Ophthalmol       Date:  2021-07-14

9.  Ethyl pyruvate treatment mitigates oxidative stress damage in cultured trabecular meshwork cells.

Authors:  Amin Famili; David A Ammar; Malik Y Kahook
Journal:  Mol Vis       Date:  2013-06-11       Impact factor: 2.367

10.  Preventive effects of omega-3 and omega-6 Fatty acids on peroxide mediated oxidative stress responses in primary human trabecular meshwork cells.

Authors:  Theofilos Tourtas; Marco T Birke; Friedrich E Kruse; Ulrich-Christoph Welge-Lüssen; Kerstin Birke
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.